BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res 2021;40:343. [PMID: 34717701 DOI: 10.1186/s13046-021-02134-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Machmouchi A, Chehade L, Temraz S, Shamseddine A. Overcoming EGFR Resistance in Metastatic Colorectal Cancer Using Vitamin C: A Review. Biomedicines 2023;11:678. [DOI: 10.3390/biomedicines11030678] [Reference Citation Analysis]
2 Jiang R, Sui Y, Hong J, Niimi M, Yan Q, Shi Z, Yao J. The Combined Administration of Vitamin C and Copper Induces a Systemic Oxidative Stress and Kidney Injury. Biomolecules 2023;13. [PMID: 36671529 DOI: 10.3390/biom13010143] [Reference Citation Analysis]
3 Mason SA, Parker L, van der Pligt P, Wadley GD. Vitamin C supplementation for diabetes management: A comprehensive narrative review. Free Radic Biol Med 2023;194:255-83. [PMID: 36526243 DOI: 10.1016/j.freeradbiomed.2022.12.003] [Reference Citation Analysis]
4 Ying M, Hu X. Tracing the electron flow in redox metabolism: The appropriate distribution of electrons is essential to maintain redox balance in cancer cells. Semin Cancer Biol 2022;87:32-47. [PMID: 36374644 DOI: 10.1016/j.semcancer.2022.10.005] [Reference Citation Analysis]
5 Jalil ZH, Sahib HB. Antiangiogenic Activity of Quinine Alone and in Combination with vitamin C in both ex vivo and in vivo Assays. Asian Pac J Cancer Prev 2022;23:4185-92. [PMID: 36580001 DOI: 10.31557/APJCP.2022.23.12.4185] [Reference Citation Analysis]
6 O'Brien K, Ried K, Binjemain T, Sali A. Integrative Approaches to the Treatment of Cancer. Cancers (Basel) 2022;14. [PMID: 36497414 DOI: 10.3390/cancers14235933] [Reference Citation Analysis]
7 Frąk M, Grenda A, Krawczyk P, Milanowski J, Kalinka E. Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients. Cancers (Basel) 2022;14. [PMID: 36428677 DOI: 10.3390/cancers14225577] [Reference Citation Analysis]
8 Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, Pritam P, Ramgopal K, Liu W, Hou K. Antioxidants in brain tumors: current therapeutic significance and future prospects. Mol Cancer 2022;21:204. [PMID: 36307808 DOI: 10.1186/s12943-022-01668-9] [Reference Citation Analysis]
9 Maekawa T, Miyake T, Tani M, Uemoto S. Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment. Front Oncol 2022;12:981547. [DOI: 10.3389/fonc.2022.981547] [Reference Citation Analysis]
10 Joo J, Chon S, Sohn K, Lee S. The Retrospective Study of Advanced Cancer Patients Receiving Integrative Cancer Treatments in single Comprehensive and Integrative Medicine Hospital. J Korean Med 2022;43:16-26. [DOI: 10.13048/jkm.22027] [Reference Citation Analysis]
11 Turpin M, Salbert G. 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer. Front Mol Biosci 2022;9:976862. [DOI: 10.3389/fmolb.2022.976862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang X, Lu J, Abudukeyoumu A, Hou D, Dong J, Wu J, Liu L, Li M, Xie F. Glucose transporters: Important regulators of endometrial cancer therapy sensitivity. Front Oncol 2022;12:933827. [DOI: 10.3389/fonc.2022.933827] [Reference Citation Analysis]
13 Liu Y, Huang P, Li Z, Xu C, Wang H, Jia B, Gong A, Xu M. Vitamin C Sensitizes Pancreatic Cancer Cells to Erastin-Induced Ferroptosis by Activating the AMPK/Nrf2/HMOX1 Pathway. Oxid Med Cell Longev 2022;2022:5361241. [PMID: 35915609 DOI: 10.1155/2022/5361241] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.5] [Reference Citation Analysis]
15 Ottone T, Faraoni I, Fucci G, Divona M, Travaglini S, De Bellis E, Marchesi F, Angelini DF, Palmieri R, Gurnari C, Giansanti M, Nardozza AM, Montesano F, Fabiani E, Lindfors Rossi EL, Cerretti R, Cicconi L, De Bardi M, Catanoso ML, Battistini L, Massoud R, Venditti A, Voso MT. Vitamin C Deficiency in Patients With Acute Myeloid Leukemia. Front Oncol 2022;12:890344. [DOI: 10.3389/fonc.2022.890344] [Reference Citation Analysis]
16 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.4] [Reference Citation Analysis]
17 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.3] [Reference Citation Analysis]
18 González-Montero J, Chichiarelli S, Eufemi M, Altieri F, Saso L, Rodrigo R. Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back. Molecules 2022;27:3818. [PMID: 35744943 DOI: 10.3390/molecules27123818] [Reference Citation Analysis]
19 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.2] [Reference Citation Analysis]
20 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t] [Reference Citation Analysis]
21 Li WN, Zhang SJ, Feng JQ, Jin WL. Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment. Cancers (Basel) 2022;14:2608. [PMID: 35681589 DOI: 10.3390/cancers14112608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dawczak-Dębicka A, Kufel-Grabowska J, Bartoszkiewicz M, Perdyan A, Jassem J. Complementary and Alternative Therapies in Oncology. Int J Environ Res Public Health 2022;19:5071. [PMID: 35564468 DOI: 10.3390/ijerph19095071] [Reference Citation Analysis]
23 Lapka M. Pharmacological possibilities of vitamin C in oncology. Vnitr Lek 2022;68:131-134. [DOI: 10.36290/vnl.2022.025] [Reference Citation Analysis]